Measuring asymmetric dimethylarginine (ADMA) in CKD: A comparison between enzyme-linked immunosorbent assay and liquid chromatographyelectrospray tandem mass spectrometry

Journal of Nephrology

Volumn 25, Issue 6, 2012, Pages 1016-1022

  Pecchini, Paola ^a   Malberti, Fabio ^a   Mieth, Maren ^b   Quinn, Robert ^c   Tripepi, Giovanni ^d   Mallamaci, Francesca ^d   Maas, Renke ^b   Zoccali, Carmine ^d   Ravani, Pietro ^c  

^a Division of Nephrology and Dialysis   (Italy)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

^d BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Asymmetric dimethylarginine; Chronic kidney disease; Enzyme linked immunosorbent assay; Liquid chromatography electrospray tandem mass spectrometry

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE;

ACCURACY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALIBRATION; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; GOLD STANDARD; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGININE; BIOLOGICAL MARKERS; CALIBRATION; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84870606512     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000085     Document Type: Article

References (11)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17): 2038-2047.
2. Zoccali C. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. J Hypertens. 2006;24(4):611-619.
3. Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun. 1996;219(2):598-603.
4. Albsmeier J, Schwedhelm E, Schulze F, Kastner M, Böger RH. Determination of NG, NG-dimethyl-L-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;809(1):59-65.
5. Martens-Lobenhoffer J, Westphal S, Awiszus F, Bode-Böger SM, Luley C. Determination of asymmetric dimethylarginine: liquid chromatography-mass spectrometry or ELISA? Clin Chem. 2005;51(11):2188-2189.
6. Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U, Böger RH. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851(1-2):211-219.
7. Schulze F, Wesemann R, Schwedhelm E, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med. 2004;42(12):1377-1383.
8. Laposata M. SI unit conversion guide. Ashford, Kent, UK: Robquest Print; 1992.
9. Schwedhelm E, Böger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7(5):275-285.
10. Sibal L, Agarwal SC, Home PD, Boger RH. The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev. 2010;6(2): 82-90.
11. Horowitz JD, Heresztyn T. An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851(1-2):42-50.